Fresenius SE

Investor News 2005

09.12.2005Fresenius obtained antitrust approval to acquire HELIOS Kliniken and the business of Clinico
PDF Text as PDF-File
01.12.2005Fresenius successfully completes capital increase
PDF Text as PDF-File
15.11.2005Fresenius fixes final subscription prices for new shares
PDF Text as PDF-File
03.11.2005Excellent financial results in the 1st-3rd quarter of 2005; full-year outlook confirmed
(for additional tables see pdf-file)
PDF Text as PDF-File
25.10.2005Fresenius resolves on capital increase and defines terms
PDF Text as PDF-File
14.10.2005Fresenius continues profitable growth
PDF Text as PDF-File
15.08.2005Extraordinary General Meeting of Fresenius Medical Care AG on August 30, 2005 – Voting of Fresenius AG
PDF Text as PDF-File
04.08.2005First half of 2005:
Fresenius achieves excellent financial results and raises full-year earnings outlook
PDF Text as PDF-File
01.07.2005Changes to Fresenius AG’s corporate credit ratings
PDF Text as PDF-File
18.05.2005ASCO-Meeting: Fresenius Biotech presents clinical trial results of new antibodies at the world’s largest cancer convention
PDF Text as PDF-File
04.05.2005First quarter 2005 and Fresenius Medical Care transactions
PDF Text as PDF-File
16.03.2005Fresenius Kabi closed acquisition of I.V. drug company Labesfal
PDF Text as PDF-File
15.03.2005Fresenius announces changes to the Management Board
PDF Text as PDF-File
02.03.2005Fresenius Kabi strengthens position in China – increases stake in joint venture from 65 % to 100 %
PDF Text as PDF-File
24.02.2005Excellent business performance in 2004; 12th consecutive dividend increase proposed; Positive outlook for 2005: 15-20 % net income growth projected
PDF Text as PDF-File
07.01.2005Fresenius Kabi continues growth strategy and acquires I.V. drug company
PDF Text as PDF-File
06.01.2005Immune Suppressive ATG-Fresenius S Receives Fast Track Status in the U.S. – First Patient Recruited in Clinical Trial
PDF Text as PDF-File
Home  >  Investor Relations  >  News  >  Investor News  >  2005